Consistently, chemical inhibition or genetic manipulation of PGAM1-Chk1 binding mitigated lung fibrosis, indicating that PGAM1-Chk1 interference is a promising senolytic for relevant disorders in aging. This evidence concerns the gene CHEK1 and pulmonary fibrosis.